Supportive Care | Specialty

Innovative Use of Technology for Palliative Care

July 19th 2015

Innovative models for palliative care delivery and primary palliative care training are springing up to address the demand–capacity mismatch.

A Comprehensive Look at Palliative Care: What Every Fellow Should Understand

July 18th 2015

Kathryn Bollin, MD, writes about the importance of enlisting palliative care at the right time, as a critical step that must be taken by any team striving to provide expert cancer care.

Dr. Chlebowski on Dietary Modifications in Patients With Breast Cancer

July 17th 2015

Rowan T. Chlebowski, MD, PhD, professor and chief, Harbor-University of California, Los Angeles Medical Center, Department of Internal Medicine, Medical Oncology/Hematology, discusses a planned follow-up analysis of the Women's Health Initiative Dietary Modification study, which examined the impact of reduced dietary fat intake in patients with breast cancer.

Dr. Temel on Anorexia and Cachexia in NSCLC

July 13th 2015

Jennifer Temel, MD, Associate Professor, Medicine, Harvard Medical School Clinical Director, Thoracic Oncology, Massachusetts General Hospital, and Associate Director, Hematology/Oncology Fellowship Program, Dana-Farber, discusses a phase III study assessing the impact of anamorelin on body weight, lean body mass, and appetite in advanced non-small cell lung cancer (NSCLC) patients with anorexia and cachexia.

Cardio-Oncology Program Puts Focus on Managing High-Risk Patients

July 8th 2015

Anju Nohria, MD, explains how the Cardio-Oncology Program originated and some of the challenges clinicians face in identifying high-risk patients and monitoring cardiovascular risks.

Adding Aprepitant Improves Control of Oxaliplatin-Related Nausea, Vomiting in CRC

July 3rd 2015

Adding an NK1 antagonist to a 5-HT3 receptor antagonist with dexamethasone improved antiemetic control for patients with colorectal cancer treated with an oxaliplatin-based regimen compared with the 5-HT3 antagonist and dexamethasone alone.

Non-Intensive Treatments for Mantle Cell Lymphoma

June 30th 2015

Treatments for Relapsed Mantle Cell Lymphoma

June 30th 2015

Upfront Treatments for Mantle Cell Lymphoma

June 30th 2015

Treating Relapsed Diffuse Large B-Cell Lymphoma

June 30th 2015

Diffuse Large B-Cell Lymphoma Treatment Regimens

June 30th 2015

Management of Refractory Follicular Lymphoma

June 30th 2015

Stem Cell Transplantation in Follicular Lymphoma

June 30th 2015

Frontline Treatments for Follicular Lymphoma

June 30th 2015

Ibrutinib in Waldenström's Macroglobulinemia

June 30th 2015

B-Cell Receptor Inhibitor Response Criteria in CLL

June 30th 2015

Emerging Strategies in CLL and Follicular Lymphoma

June 30th 2015

Ibrutinib-Associated Adverse Events

June 30th 2015

Ibrutinib Monotherapy and Combinations in CLL

June 30th 2015

Preventing Infusion Reactions With CD20 Antibodies in CLL

June 30th 2015